Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kezar Life Sciences Inc.

    NASDAQ: KZR · Real-Time Price · USD
    4.11
    -0.23 (-5.30%)
    At close: Jun 17, 2025, 3:59 PM
    4.13
    0.49%
    After-hours: Jun 17, 2025, 07:39 PM EDT

    Kezar Life Sciences Statistics

    Share Statistics

    Kezar Life Sciences has 7.31M shares outstanding. The number of shares has increased by -89.96% in one year.

    Shares Outstanding

    n/a
    		 7.31M

    Shares Change (YoY)

    n/a
    		 -89.96%

    Shares Change (QoQ)

    n/a
    		 0.13%

    Owned by Institutions (%)

    n/a
    		 5.73%

    Shares Floating

    n/a
    		 6.22M

    Failed to Deliver (FTD) Shares

    n/a
    		 288

    FTD / Avg. Volume

    n/a
    		 0.95%

    Short Selling Information

    The latest short interest is 49.16K, so 0.67% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 49.16K

    Short % of Shares Out

    n/a
    		 0.67%

    Short % of Float

    n/a
    		 0.69%

    Short Ratio (days to cover)

    n/a
    		 3.69

    Valuation Ratios

    The PE ratio is -5.85 and the forward PE ratio is -0.72. Kezar Life Sciences's PEG ratio is 0.33.

    PE Ratio

    n/a
    		 -5.85

    Forward PE

    n/a
    		 -0.72

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.4

    PB Ratio

    n/a
    		 4.19

    P/FCF Ratio

    n/a
    		 -6.6

    PEG Ratio

    n/a
    		 0.33
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Kezar Life Sciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.76, with a Debt / Equity ratio of 0.14.

    Current Ratio

    n/a
    		 6.76

    Quick Ratio

    n/a
    		 6.76

    Debt / Equity

    n/a
    		 0.14

    Debt / EBITDA

    n/a
    		 -0.2

    Debt / FCF

    n/a
    		 -0.22

    Interest Coverage

    n/a
    		 -56.88

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,522,472.73

    Employee Count

    n/a
    		 55

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -93.4% in the last 52 weeks. The beta is 0.57, so Kezar Life Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.57

    52-Week Price Change

    n/a
    		 -93.4%

    50-Day Moving Average

    n/a
    		 4.26

    200-Day Moving Average

    n/a
    		 12

    Relative Strength Index (RSI)

    n/a
    		 48.86

    Average Volume (20 Days)

    n/a
    		 30,368

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -90.61M

    Net Income

    n/a
    		 -83.74M

    EBITDA

    n/a
    		 -81.1M

    EBIT

    n/a
    		 -85.33M

    Earnings Per Share (EPS)

    n/a
    		 -1.15
    Full Income Statement

    Balance Sheet

    The company has 41.75M in cash and 16.18M in debt, giving a net cash position of 25.57M.

    Cash & Cash Equivalents

    n/a
    		 41.75M

    Total Debt

    n/a
    		 16.18M

    Net Cash

    n/a
    		 25.57M

    Retained Earnings

    n/a
    		 -434.5M

    Total Assets

    n/a
    		 125.26M

    Working Capital

    n/a
    		 103.36M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -74.21M and capital expenditures -29K, giving a free cash flow of -74.24M.

    Operating Cash Flow

    n/a
    		 -74.21M

    Capital Expenditures

    n/a
    		 -29K

    Free Cash Flow

    n/a
    		 -74.24M

    FCF Per Share

    n/a
    		 -1.02
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    KZR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for KZR is $9, which is 105.5% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $9

    Price Target Difference

    n/a
    		 105.5%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 30, 2024. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Oct 30, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -5.22

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist